Investing in a real estate investment trust (Reit) generally benefits the world in a positive way. Real estate has been severely impacted by the recent COVID-19 pandemic. It is now beginning to recover. Investors would do well to integrate the best REITs into their portfolios.
Considering their different focus areas, REITs are not an easy portfolio investment to choose from. It’s nearly impossible to pick one that’s right for your portfolio. Divulging your portfolio or choosing multiple stocks will help you reach this goal.
In addition to income yield and inflation protection, real estate investment trusts have several other benefits. Another advantage is that they generate passive income. Because of this, they are extremely popular investments.
This should be taken into account when evaluating stocks and REITs. The best way to invest in real estate is usually in REIT ETFs rather than in individual stocks. The key characteristics of real estate investment trusts (REITs) are low costs and ease of diversification. These trusts usually pay dividends as well.
Investing in REITs might have been on your radar in the past. How should you go about it? Check out these tips.
When considering the properties listed above, these three best REITs stocks represent the best buys right now.
Welltower Inc. (WELL)’s stock price was $81.92 at the previous market close, with its latest volume reaching 2.68 million. Compare that to its average daily volume of 1.92M. Given the fact that this stock has 428.03M shares outstanding, its current market value is sitting at $82.04.
Barclays rated the Welltower Inc. (NYSE: WELL) stock “an Overweight”. Barclays’s estimates were contained in a research note released on Wednesday, November 17, 2021. Several other experts on Wall Street have posted such reports regarding the well shares. According to BMO Capital Markets, the stock is “an Outperform,”$100. BMO Capital Markets published its figures in a research note released to investors on Thursday, August 26, 2021. Other experts at Berenberg have the stock’s price target at $100 price; with their rating of the stock is “a Buy.”. These scores were published in a research note the firm released on Tuesday, August 03, 2021.
Healthcare Trust of America Inc. (NYSE: HTA) is currently trading at around $34.02, a price level that means its value has jumped 34.41% higher than its 52-week low. In intraday trading, HTA shares have hit a high of $34.40 and a low of $33.915. The last 52 weeks have seen the company’s shares touch a high of $34.75 and a low of $25.31, while the recent trading session has witnessed an intraday change of just -0.64%.
Multiple groups of Wall Street analysts have recently been drawn to the HTA stock, with those at Berenberg Downgrade the stock to an “a Hold”a Buy. The analysts released their assessment via a research note they published on November 24, 2021. Analysts at Truist maintained their earlier rating, although they did raise the stock’s price target to $31. Over at Raymond James, the analysts restated the earlier stance about Healthcare Trust of America Inc. shares, rating the shares “an Mkt perform.” in a note released August 20, 2021.
Healthpeak Properties Inc. (NYSE:PEAK) does about 2.87M shares in volume on a normal day but saw 1.95 million shares change hands in Monday trading. The company now has a market cap of $18.69 billion. Its current market price is $34.06, marking an increase of 0.47% compared to the previous close of $33.90. The 52 week high reached by this stock is $37.69 whilst the lowest price level in 52 weeks is $28.15. The script in recent trading has seen the stock touched a high of $34.41 and a low of $33.85.
With this outlook, analysts have a consensus recommendation rating of 2.30 for the stock, suggesting that investors Overweight the stock. Mizuho issued a stock update for Healthpeak Properties Inc. (PEAK) on July 14, 2021 in which the firm assigned a “Neutral” rating. JP Morgan on May 20, 2021, rated the stock at “a Neutral,”. 17 analysts offering their rating for the stock are split like this: 8 of the 17 rates it as a Hold; 8 see it as a buy, while 1 say it is overweight. Although bearish, it is notable that the stock is well above its 200-day simple moving average by 0.53%, while it is -0.93% below and -1.13% below its SMA50 and SMA20 respectively. The volume of shares traded in the last session stands at 1.95 million against a 3-month average of 2.87M.